Verrica Pharmaceuticals Inc (VRCA)
7.29
+0.07
(+0.97%)
USD |
NASDAQ |
Jun 28, 16:00
7.27
-0.02
(-0.27%)
After-Hours: 20:00
Verrica Pharmaceuticals Gross Profit (TTM): 7.097M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 7.097M |
December 31, 2023 | 4.378M |
September 30, 2023 | 2.668M |
Date | Value |
---|---|
June 30, 2023 | 8.174M |
March 31, 2023 | 8.123M |
December 31, 2022 | 8.307M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
2.668M
Minimum
Sep 2023
8.307M
Maximum
Dec 2022
6.458M
Average
7.61M
Median
Gross Profit (TTM) Benchmarks
Emergent BioSolutions Inc | 460.50M |
Macrogenics Inc | 34.99M |
Aquestive Therapeutics Inc | 31.02M |
Recursion Pharmaceuticals Inc | 3.927M |
Omega Therapeutics Inc | -- |